EUVIMEDEUVIMED entdecken
Crossref

Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis

Zhihui Wang, Ruikun Zhang, Dong Dai, Meiling Zhang, Dapeng Gao, Jie Zhang, Zhifang Wu, Kangli Hui, Jingwei Xiong, Hao Cheng, Jiali Xu, Qing Ji

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.116182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Zhihui Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Hauptthemen laut MEDLINE: Reperfusion Injury, Blood-Brain Barrier, Neuroprotective Agents, Brain Ischemia. Die Arbeit nennt 57 Literaturangaben. Gefördert von: General Hospital of Eastern Theatre Command, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of cerebral ischemia-reperfusion injury centers on neuroinflammation and oxidative stress-induced programmed cell death. Although remimazolam(REM) is a clinically used benzodiazepine sedative, its neuroprotective effects against various cell death modalities remain incompletely characterized. Cerebral ischemia-reperfusion injury induced significant cerebral edema, marked oxidative stress, elevated inflammatory factor expression, and substantial blood-brain barrier disruption. REM treatment significantly improved neurological deficits, reduced cerebral infarction volume, enhanced ZO-1 and occludin expression in the cerebral cortex, decreased Evans blue leakage, protected blood-brain barrier integrity, In the hippocampus, REM treatment also significantly inhibited neuroinflammation and oxidative stress, lowered pro-inflammatory factors (TNF-α and IL-1β), mitigated ROS-induced damage, blocked NLRP3 inflammasome activation, suppressed caspase-1 cleavage and GSDMD channel formation, downregulated RIP3/MLKL expression, reduced necroptosis, and improved motor function in rats. REM ameliorates cerebral ischemia-reperfusion injury through dual inhibition of the neuroinflammatory-oxidative stress cascade and concurrent blockade of both NLRP3/GSDMD-mediated pyroptosis and RIP3/MLKL-driven necroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryBlood-Brain BarrierNeuroprotective AgentsBrain IschemiaAnimalsReceptor-Interacting Protein Serine-Threonine KinasesMaleNecroptosisOxidative StressNLR Family, Pyrin Domain-Containing 3 ProteinProtein KinasesRatsRats, Sprague-DawleyGasderminsIntracellular Signaling Peptides and ProteinsPhosphate-Binding Proteins

Stichwörter der Autor:innen

Blood-brain barrierNecroptosisNeuroinflammationPyroptosisRemimazolam

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesNeuroprotective AgentsRipk3 protein, ratNLR Family, Pyrin Domain-Containing 3 ProteinProtein KinasesMLKL protein, ratNlrp3 protein, ratGsdmd protein, ratGasderminsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China.
  • Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Electronic address: chenghao927@126.com.
  • Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Electronic address: xjl15950466318@163.com.
  • Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Electronic address: qing_ji@nju.edu.cn.

Förderung

  • General Hospital of Eastern Theatre Command
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Z., Zhang, R., Dai, D., Zhang, M., Gao, D., Zhang, J., Wu, Z., Hui, K., Xiong, J., Cheng, H., Xu, J., & Ji, Q. (2026). Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116182

Vancouver

Wang Z, Zhang R, Dai D, Zhang M, Gao D, Zhang J, et al. Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116182

BibTeX
@article{Wang2026,
  author = {Wang, Zhihui and Zhang, Ruikun and Dai, Dong and Zhang, Meiling and Gao, Dapeng and Zhang, Jie and Wu, Zhifang and Hui, Kangli and Xiong, Jingwei and Cheng, Hao and Xu, Jiali and Ji, Qing},
  title = {Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.116182}
}
Kostenlos starten →